JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CSW
2426
CSW Industrials
CSW
$4.87B
| $6.58M | ﹤0.01% |
63,826
+4,545
| +8% | +$485K |
2017 Q4
18 quarters
|
|
|
PAQCU
2427
DELISTED
Provident Acquisition Corp. Units
PAQCU
| $6.57M | ﹤0.01% |
+664,000
| New | +$6.62M |
2022 Q2
0 quarters
|
|
2428
ProShares Equities for Rising Rates ETF
EQRR
$37.5M
| $6.57M | ﹤0.01% |
146,487
-39,132
| -21% | -$2.01M |
2022 Q1
1 quarter
|
|
|
SRNE
2429
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $6.57M | ﹤0.01% |
3,269,037
-29,062
| -0.9% | -$50.2K |
2018 Q2
16 quarters
|
|
2430
Vanguard International High Dividend Yield ETF
VYMI
$20.9B
| $6.55M | ﹤0.01% |
111,388
+1,829
| +2% | +$117K |
2018 Q1
17 quarters
|
|
2431
Newmark Group
NMRK
$2.38B
| $6.54M | ﹤0.01% |
676,826
-34,944
| -5% | -$405K |
2017 Q4
18 quarters
|
|
2432
CALL
Dow Inc
DOW
$20.1B
| $6.54M | ﹤0.01% |
126,700
-14,100
| -10% | -$903K |
2020 Q4
6 quarters
|
|
2433
CALL
Monster Beverage
MNST
$83.1B
| $6.54M | ﹤0.01% |
282,000
+228,400
| +426% | +$4.97M |
2021 Q3
3 quarters
|
|
2434
AXIS Capital
AXS
$6.93B
| $6.53M | ﹤0.01% |
114,294
-11,629
| -9% | -$663K |
2013 Q2
36 quarters
|
|
2435
Black Stone Minerals
BSM
$3.09B
| $6.52M | ﹤0.01% |
476,344
+50,916
| +12% | +$773K |
2015 Q2
28 quarters
|
|
2436
PUT
Exelon
EXC
$42.1B
| $6.49M | ﹤0.01% |
143,100
+121,200
| +553% | +$5.7M |
2021 Q1
5 quarters
|
|
2437
Ollie's Bargain Outlet
OLLI
$5.17B
| $6.47M | ﹤0.01% |
110,072
-89,606
| -45% | -$4.53M |
2015 Q3
27 quarters
|
|
2438
Alpha and Omega Semiconductor
AOSL
$911M
| $6.46M | ﹤0.01% |
193,756
-123
| -0.1% | -$5.04K |
2013 Q2
36 quarters
|
|
2439
PUT
VanEck Gold Miners ETF
GDX
$26.2B
| $6.46M | ﹤0.01% |
31,700
-192,000
| -86% | -$6.48M |
2013 Q2
36 quarters
|
|
2440
CALL
Dollar General
DG
$26.1B
| $6.46M | ﹤0.01% |
26,300
-26,600
| -50% | -$6.21M |
2021 Q3
3 quarters
|
|
2441
Aclaris Therapeutics
ACRS
$664M
| $6.44M | ﹤0.01% |
461,596
+416,946
| +934% | +$5.84M |
2017 Q4
18 quarters
|
|
|
KSI
2442
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
| $6.43M | ﹤0.01% |
657,984
-64,098
| -9% | -$625K |
2021 Q2
4 quarters
|
|
|
MNDT
2443
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $6.42M | ﹤0.01% |
294,127
-411,823
| -58% | -$9.05M |
2013 Q4
34 quarters
|
|
2444
CALL
Chubb
CB
$127B
| $6.41M | ﹤0.01% |
32,600
| – | – |
2020 Q4
6 quarters
|
|
2445
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$765M
| $6.4M | ﹤0.01% |
203,989
-2,694
| -1% | -$90.3K |
2014 Q3
31 quarters
|
|
2446
Varex Imaging
VREX
$786M
| $6.38M | ﹤0.01% |
298,410
-48,990
| -14% | -$1.04M |
2017 Q1
21 quarters
|
|
2447
PUT
ARK Innovation ETF
ARKK
$9.82B
| $6.38M | ﹤0.01% |
160,000
-267,400
| -63% | -$12.7M |
2021 Q1
5 quarters
|
|
2448
Banc of California
BANC
$2.84B
| $6.38M | ﹤0.01% |
362,149
+134,274
| +59% | +$2.45M |
2017 Q2
20 quarters
|
|
2449
Titan Machinery
TITN
$575M
| $6.38M | ﹤0.01% |
284,602
+1,889
| +0.7% | +$47.1K |
2015 Q4
26 quarters
|
|
2450
Preferred Bank
PFBC
$1.27B
| $6.37M | ﹤0.01% |
93,652
+1,317
| +1% | +$90.2K |
2013 Q2
36 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.